Physician profile
Anne D Redding
NPI 1528067790
$1,795.53
in general payments reported to CMS, 2019-2025
17 companies · $402 in 2025
The $402 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $111 · 2021: $115 · 2022: $114 · 2023: $221 · 2024: $708 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $360.37 | 2023-2025 | |
| Biogen, INC. | $331.46 | 2022-2025 | Tysabri, Vumerity, Tecfidera |
| Jazz Pharmaceuticals INC. | $226.12 | 2020-2021 | |
| Abbvie INC. | $141.95 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $124.78 | 2019 | |
| Ucb, INC. | $121.99 | 2024 | Rystiggo |
| Pfizer INC. | $112.18 | 2023-2025 | |
| Averitas Pharma INC. | $90.33 | 2023-2025 | Qutenza |
| Tg Therapeutics, INC. | $66.29 | 2024-2025 | |
| Lundbeck LLC | $60.10 | 2023-2024 | Vyepti |
| Novartis Pharmaceuticals Corporation | $33.64 | 2022-2023 | |
| Genentech, INC. | $26.17 | 2024 | Ocrevus |
| Genentech USA, INC. | $24.66 | 2024 | Ocrevus |
| Acadia Pharmaceuticals INC | $23.70 | 2025 | Daybue |
| Biohaven Pharmaceutical Holding Company LTD. | $20.95 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $16.11 | 2022 | |
| Amgen INC. | $14.73 | 2023 | Aimovig |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Redding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.